文献速递腹部CTMR

LI-RADS分类与临床病理特征预测根治性切除肝细胞癌患者的无复发生存

LI-RADS categories and clinicopathological features predict recurrence-free survival in patients with radical resected hepatocellular carcinoma.
PubMed 文献 · Eur J Radiol · 2025-11-17

本回顾性研究纳入2014年1月至2018年7月间接受手术切除的218例肝细胞癌患者,由两名放射科医师独立评估LI-RADS v2018分类。多因素Cox回归显示肿瘤最大径、肿瘤数目>1、LI-RADS分类LR-TIV及MVI分级M2为无复发生存独立危险因素,并据此构建列线图,预测1年、2年、5年RFS的AUC分别为0.84、0.77、0.77,结论认为该列线图可为术后RFS预测提供实用工具。

要点

  • LI-RADS分类LR-TIV是根治性切除后无复发生存的独立危险因素(HR=2.01)。
  • 肿瘤最大径、肿瘤数目>1及MVI分级M2均为RFS独立危险因素。
  • 联合上述因素的列线图预测1年RFS的AUC为0.84。

核心结论

  • 结合LI-RADS分类、肿瘤最大径和数目以及MVI分级的列线图可为肝细胞癌患者术后无复发生存预测提供实用工具。

研究设计与样本

  • 回顾性研究,纳入2014年1月至2018年7月间接受手术切除的肝细胞癌患者218例(平均年龄49.47±11.14岁,男性184例),由两名放射科医师独立评估LI-RADS v2018分类,记录临床病理参数,采用单因素及多因素Cox回归分析筛选RFS独立危险因素并构建列线图,通过ROC曲线分析评估性能,采用bootstrap重采样进行内部验证并以校准曲线和C-index评估模型一致性。

诊断标准与关键数值

  • 多因素分析显示肿瘤最大径(HR=1.01,95%CI:1.01,1.01,p<0.001)、肿瘤数目>1(HR=1.95,95%CI:1.39,2.74,p<0.001)、LI-RADS分类LR-TIV(HR=2.01,95%CI:1.33,3.04,p<0.001)及MVI分级M2(HR=2.70,95%CI:1.70,4.31,p<0.001)为RFS独立危险因素;列线图预测1年、2年、5年RFS的AUC分别为0.84(95%CI:0.79,0.89)、0.77(95%CI:0.71,0.83)、0.77(95%CI:0.69,0.84);bootstrap校正C-index为0.73(95%CI:0.69,0.77)。

临床应用与阅片要点

  • 阅片时可依据LI-RADS v2018分类评估LR-TIV等类别,并结合肿瘤最大径、肿瘤数目及MVI分级等信息,为根治性切除术后肝细胞癌患者的无复发生存预测提供参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the value of LI-RADS categories and clinicopathological characteristics in predicting recurrence-free survival (RFS) after radical resection of hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: This retrospective study included HCC patients who underwent surgical resection between January 2014 and July 2018. Two radiologists independently evaluated the LI-RADS v2018 categories. Clinicopathological parameters were documented. Univariate and multivariate Cox regression analyses were performed to identify independent risk factors for RFS. These risk factors were then used to constructe a nomogram, its performance was evaluated with receiver operating characteristic (ROC) curve analysis. Internal validation was performed via bootstrap resampling, with calibration curves and the C-index assessing model consistency.

RESULTS: A total of 218 patients (mean age: 49.47 ± 11.14 years; 184 males) were included. Multivariate analysis revealed that tumor maximum diameter (hazard ratio (HR) = 1.01 [95 % confidence interval (CI): 1.01, 1.01], p < 0.001), tumor number (>1; HR = 1.95 [95 % CI: 1.39, 2.74], p < 0.001), LI-RADS category ((LR-TIV: HR = 2.01 [95 % CI: 1.33, 3.04], p < 0.001), and MVI grading (M2: HR = 2.70 [95 % CI: 1.70, 4.31], p < 0.001) were independent risk factors and were used to construct a nomogram. The areas under the ROC curves (AUCs) in predicting the 1-, 2-, and 5-year RFS rates were 0.84 (95 % CI: 0.79, 0.89), 0.77 (95 % CI: 0.71, 0.83) and 0.77 (95 % CI: 0.69, 0.84), respectively. The bootstrap-corrected C-index was 0.73 (95 % CI: 0.69, 0.77).

CONCLUSION: The nomogram combining LI-RADS category, tumor maximum diameter and number, and MVI grading could provide a practical tool for post-resection RFS prediction in HCC patients.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Cao S, Mu L, Li J, et al. LI-RADS categories and clinicopathological features predict recurrence-free survival in patients with radical resected hepatocellular carcinoma. Eur J Radiol. 2025. PMID: 41270705. doi:10.1016/j.ejrad.2025.112535

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。